Accelerate Diagnostics Completes Clinical Data Collection, Will Present Data at the William Blair 36th Annual Growth Stock ...
TUCSON, Ariz., June 14, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“Accelerate”) announced today the completion of clinical data collection intended for submission to the FDA in conjunction with its de novo 510k request for premarket clearance …